BioCentury
ARTICLE | Clinical News

APD334: Phase I started

April 15, 2013 7:00 AM UTC

Arena began a double-blind, placebo-controlled Phase I trial to evaluate single ascending-doses of APD334 in up to 64 healthy volunteers. ...